GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Simulations Plus Inc (NAS:SLP) » Definitions » Sloan Ratio %

Simulations Plus (Simulations Plus) Sloan Ratio % : 4.58% (As of Feb. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Simulations Plus Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Simulations Plus's Sloan Ratio for the quarter that ended in Feb. 2024 was 4.58%.

As of Feb. 2024, Simulations Plus has a Sloan Ratio of 4.58%, indicating the company is in the safe zone and there is no funny business with accruals.


Simulations Plus Sloan Ratio % Historical Data

The historical data trend for Simulations Plus's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Simulations Plus Sloan Ratio % Chart

Simulations Plus Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.43 43.89 9.62 -5.16 -10.35

Simulations Plus Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.51 -14.23 -10.35 -1.92 4.58

Competitive Comparison of Simulations Plus's Sloan Ratio %

For the Health Information Services subindustry, Simulations Plus's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Simulations Plus's Sloan Ratio % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Simulations Plus's Sloan Ratio % falls into.



Simulations Plus Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Simulations Plus's Sloan Ratio for the fiscal year that ended in Aug. 2023 is calculated as

Sloan Ratio=(Net Income (A: Aug. 2023 )-Cash Flow from Operations (A: Aug. 2023 )
-Cash Flow from Investing (A: Aug. 2023 ))/Total Assets (A: Aug. 2023 )
=(9.961-21.856
-7.366)/186.101
=-10.35%

Simulations Plus's Sloan Ratio for the quarter that ended in Feb. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Feb. 2024 )
=(10.516-17.58
--15.941)/193.973
=4.58%

Simulations Plus's Net Income for the trailing twelve months (TTM) ended in Feb. 2024 was 4.008 (May. 2023 ) + 0.534 (Aug. 2023 ) + 1.945 (Nov. 2023 ) + 4.029 (Feb. 2024 ) = $10.52 Mil.
Simulations Plus's Cash Flow from Operations for the trailing twelve months (TTM) ended in Feb. 2024 was 8.548 (May. 2023 ) + 3.06 (Aug. 2023 ) + 0.162 (Nov. 2023 ) + 5.81 (Feb. 2024 ) = $17.58 Mil.
Simulations Plus's Cash Flow from Investing for the trailing twelve months (TTM) ended in Feb. 2024 was 7.919 (May. 2023 ) + 0.52 (Aug. 2023 ) + -16.864 (Nov. 2023 ) + -7.516 (Feb. 2024 ) = $-15.94 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Simulations Plus  (NAS:SLP) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Feb. 2024, Simulations Plus has a Sloan Ratio of 4.58%, indicating the company is in the safe zone and there is no funny business with accruals.


Simulations Plus Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Simulations Plus's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Simulations Plus (Simulations Plus) Business Description

Traded in Other Exchanges
N/A
Address
42505 Tenth Street West, Lancaster, CA, USA, 93534-7059
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. It generates maximum revenue from the software segment.
Executives
John Kenneth Paglia director 746 GRABLE PLACE, NEWBURY PARK CA 91320
Walter S Woltosz director, 10 percent owner, officer: Chairman and CEO 42505 10TH ST. WEST, LANCASTER CA 93534
Dibella John Anthony Ii officer: Division President 42505 10TH STREET WEST, LANCASTER CA 93534
Lisa Lavange director 42505 10TH ST., WEST, LANCASTER CA 93534
Steven Chang officer: President, Immunetrics 42505 10TH STREET WEST, LANCASTER CA 15203
Shawn Oconnor officer: Chief Executive Officer 42505 10TH STREET WEST, LANCASTER CA 93534-7059
Jill Fiedler-kelly officer: President, Cognigen Division 42505 10TH STREET WEST, LANCASTER CA 93534
Brett Howell officer: President, DILIsym Division 42505 10TH STREET WEST, LANCASTER CA 93534
William W Frederick officer: CFO C/O SIMULATIONS PLUS, INC., 42505 10TH STREET WEST, LANCASTER CA 93534
Daniel L Weiner director 800 WEST EL CAMINO REAL, SUITE 200, MOUNTAIN VIEW CA 94040
Sharlene Evans director 42505 10TH STREET WEST, LANCASTER CA 93534
Nguyen Nguyen officer: VP of Human Resources 42505 TENTH STREET WEST, LANCASTER CA 93534
David L. Ralph director 42505 10TH STREET WEST, LANCASTER CA 93534
John Robert Kneisel officer: CFO 42505 10TH STREET WEST, LANCASTER CA 93534
Grasela Thaddeus Henry Jr director, officer: President 1780 WEHRLE DRIVE SUITE 110, BUFFALO NY 14221